Season 03: episode 08
In this week’s episode, GOLD speaks to Patrick Short, CEO, Sano Genetics, about the challenges and opportunities facing genetic medicine today.
He discusses his personal connection to genetic disease, the reasons behind participation hesitancy and the therapy areas in which he believes genomic testing and medicine could be most impactful.
And in news you might have missed, the team explores some stories that emerged from the recent World Health Summit, including new funding for polio and antibiotic resistance research.
A little more on GOLD’s guest…
Patrick Short, CEO, Sano Genetics, has a background in genomics research with a focus on large-scale genome sequencing projects and rare disorders. While completing a PhD in Mathematical Genomics and Medicine from the Wellcome Trust Sanger Institute and the University of Cambridge, he came up with the idea for Sano Genetics. The company was founded in 2017 and has a mission to connect patients to genetic research opportunities to support the future of personalised medicine.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Click here to subscribe to the weekly newsletter for more insights from GOLD.